Agilent (A) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures - Yahoo Finance
#Analysts' Insights#Key Performance#Performance Measures#Yahoo Finance#Measures Yahoo
Life Science News
Latest updates from the biotech and pharma world
Will Waters Corporation stock reach all time highs in 2025 - Quarterly Portfolio Review & Technical Analysis for Trade Confirmation - newser.com
#Quarterly Portfolio#Portfolio Review#Technical Analysis#Waters Corporation#Trade Confirmation
C. Light Named One of Five Selected Projects in the Roche MS Innovation Challenge - Yahoo Finance
#Light Named#Selected Projects#Innovation Challenge#Yahoo Finance#Challenge Yahoo
Sapphiros announces a strategic agreement with Roche, providing Roche access to 1 billion lateral flow tests and access to future molecular point-of-care tests - Yahoo Finance
#providing Roche#Yahoo Finance#Roche access#billion lateral#future molecular
Thermo Fisher Scientific Launches Industry-First, Multi-Parameter Molecular Assay for Rapid Beverage Quality Testing - Morningstar
#Fisher Scientific#Scientific Launches#Molecular Assay#Rapid Beverage#Beverage Quality
KaliVir Immunotherapeutics Announces Clinical Trial Collaboration and Supply Agreement with Roche to Evaluate VET3-TGI in Combination with Atezolizumab (Tecentriq®) in Advanced Solid Tumors - Yahoo Finance
#Immunotherapeutics Announces#Announces Clinical#Clinical Trial#Trial Collaboration#Supply Agreement
What momentum indicators show for Agilent Technologies Inc. stock - 2025 Technical Patterns & Weekly Return Optimization Plans - newser.com
#Agilent Technologies#Technical Patterns#Weekly Return#Return Optimization#Optimization Plans
Olema Pharmaceuticals (OLMA) Rethinks Competitive Edge After Roche’s Breast Cancer Trial Success - Yahoo Finance
#Rethinks Competitive#Competitive Edge#Breast Cancer#Cancer Trial#Olema Pharmaceuticals
Analyzing recovery setups for Agilent Technologies Inc. investors - Market Trend Report & AI Optimized Trading Strategy Guides - newser.com
#Agilent Technologies#Market Trend#Trend Report#Optimized Trading#Trading Strategy
3 Reasons to Sell ILMN and 1 Stock to Buy Instead - Finviz
#Sell ILMN#Reasons#Stock#Sell#ILMN
What Thermo Fisher Scientific (TMO)'s FDA Clearance for EXENT System Means for Shareholders - simplywall.st
#Fisher Scientific#Thermo Fisher#FDA Clearance#EXENT System#Shareholders simplywall.st
Roche: Data for Breast Cancer Drug Candidate Giredestrant Support Potential Differentiated Status - Morningstar Canada
#Breast Cancer#Cancer Drug#Drug Candidate#Candidate Giredestrant#Giredestrant Support
3 Reasons to Avoid TXG and 1 Stock to Buy Instead - Finviz
#Avoid TXG#Reasons#Stock#Avoid#TXG
Lone Star, Altaris, One Rock Said Among Bidders for Lonza Assets - Bloomberg.com
#Lone Star#Lonza Assets#Assets Bloomberg.com#Altaris#Bloomberg.com Lone
Freenome and Roche partner on cancer screening technology for ex-US markets - Medical Device Network
#Medical Device#Device Network#Roche partner#cancer screening#screening technology
Creative Planning Grows Stock Position in Agilent Technologies, Inc. $A - MarketBeat
#Agilent Technologies#Planning Grows#Grows Stock#Stock Position#Creative Planning
As Madrigal faces MASH rivals, keeping patients is as critical as finding new ones
#MASH rivals#faces MASH#drug Rezdiffra#exceeded expectations#Madrigal faces
Agilent Technologies Inc. stock outlook for YEAR - 2025 Investor Takeaways & Long-Term Growth Portfolio Plans - newser.com
#Investor Takeaways#Agilent Technologies#Growth Portfolio#Long-Term Growth#Portfolio Plans
European Commission approves Roche’s Lunsumio subcutaneous for relapsed or refractory follicular lymphoma - Yahoo Finance
#Yahoo Finance#European Commission#Commission approves#approves Roche#Lunsumio subcutaneous
Is Agilent Technologies Inc. (AG8) stock prepared for digital transition - Weekly Investment Recap & AI Based Buy and Sell Signals - newser.com
#Agilent Technologies#Weekly Investment#Investment Recap#Based Buy#Sell Signals